SimExpr2SampleData

SimExpr2SampleData simulates microarray expression datasets and assesses classification and feature selection methodologies to evaluate biomarker discovery under disease heterogeneity and limited sample sizes.

Key Features:

• Simulation Schema: Employs an in silico regulation network model to simulate intrinsic population variability and alterations in regulatory mechanisms, replicating disease heterogeneity.
• Benchmarking with Known Biomarkers: Uses simulated datasets alongside real clinical data to benchmark classification and feature selection methods by comparison to known biomarkers.
• External Cross-Validation Loops: Incorporates external cross-validation loops to enhance identification of features with higher precision and stability.
• Performance Evaluation Across Sample Sizes and Heterogeneity: Evaluates performance of classification and feature selection methodologies under varying sample sizes and heterogeneity conditions.
• Controlled Assessment Environment: Provides a controlled simulation environment to systematically assess the impact of population variability and regulatory alterations on biomarker discovery.

Scientific Applications:

• Biomarker Discovery: Aids identification of robust molecular biomarkers by simulating disease heterogeneity and population variability.
• Methodological Assessment: Enables evaluation of advantages and drawbacks of classification and feature selection methods across simulated conditions.
• Precision Medicine: Supports development of personalized medicine approaches by improving precision of biomarker identification.

Methodology:

Models intrinsic population variability and specific alterations in regulatory mechanisms to simulate disease heterogeneity; assesses how different computational approaches perform across varying sample sizes and heterogeneity; validates simulation findings by applying them to real clinical data.